Thrive Living has started work on a 290‑unit modular affordable housing project at 1141 N. Vermont, steps from the Vermont/Santa Monica Metro station. The build is privately financed and fast‑tracked under Executive Directive 1.

Developer Azure plans to remake the long‑vacant Reseda Theatre into a 15,860 sq ft food hall with an upstairs microcinema and restored marquee.

A Los Angeles man has been charged in the 1996 killing of Claudia Guevara after investigators linked him to the case with DNA evidence. Prosecutors allege rape and sodomy alongside the murder charge.

A shooting was reported Monday across from a North Hollywood high school; one person was shot and a potential suspect was detained.

A teenager was wounded Monday near a North Hollywood Taco Bell. Authorities have released few details as investigators work the scene.

Patchy fog this morning turns to rain late Tuesday with gusty southerly winds and high surf along the coast. Allow extra travel time.

Three people were wounded in a shooting near San Carlos and E. Chavez in East Los Angeles; deputies set up a containment while the search for the gunman continues.

A Montclair Mongols member was sentenced to five years after pleading guilty to an assault tied to a March bar shooting that killed a rival biker in Ontario.

DOCS Health’s five‑story surgical tower in Mid‑Wilshire is now enclosed and moving into interior build‑out; the 55,000‑sq‑ft, $150M facility aims to open late 2026.

An early-morning takeover in West Long Beach left a car ablaze and two people hurt in a separate crash. Police and firefighters are investigating.

Sunny Monday with highs near 80°F. Rain likely Tuesday night and elevated surf advisories through Wednesday.

Santa Monica is sponsoring AB 1740, a state bill that would let transit-rich coastal cities approve certain housing and street projects without individual Coastal Commission review. Supporters call it a fast-track for housing and bike lanes; others worry about lost oversight.

Culver City‑based ImmunityBio jumped after recent regulatory nods abroad and a productive FDA meeting, boosting sales figures and analyst interest. The company is now pushing to turn approvals into global distribution.